Michael Andreou | Value & Access Lead, Rare Diseases, Biogen
Biogen

Michael Andreou is a market access & pricing leader with over 25 years access and commercial strategy experience in pharma & biotech. He has broad therapeutic area experience, especially in rare diseases, and is currently global Value & Access Lead in Rare Diseases at Biogen focusing on access & pricing strategy and execution. Michael has an MBA (Oxford), a health economics masters (LSE) and a molecular biology masters (Berkeley).